Purchase Order 75N94023P00566
Award Date
9/28/23
Potential Completion Date
9/27/24
Potential Value
$232K
Funding Federal Agency
National Institute of Diabetes and Digestive and Kidney Diseases
Contracting Federal Agency
National Institute of Child Health and Human Development
Awardee
Bruker Biospin Corp
Ultimate Awardee
Bruker Corporation
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Billerica, MA 01821, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a non-competitive, single-source $152,119.10 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Bruker Biospin Corp for annual service and maintenance of seven Bruker CryoPlatform NMR spectrometer systems. The contract covers remote diagnosis, repairs, and scheduled overhaul maintenance to ensure the continued operation of these critical scientific instruments used for protein structure and interaction research...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has awarded a $216,684 firm-fixed price purchase order to Bruker Biospin Corp. for a CryoPlatformTM Maintenance Agreement. This agreement will provide critical maintenance services for the agency's Nuclear Magnetic Resonance (NMR) spectrometers used in protein research. Bruker Biospin Corp. is the sole source provider of the proprietary CryoPlatform equipment and authorized maintenance services. This purchase order does...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), awarded a firm-fixed price purchase order valued at approximately $1.2 million to Bruker Biospin Corp. to acquire upgrades to three nuclear magnetic resonance (NMR) spectrometer systems. The upgrades include the 500 MHz and 800 MHz NMR consoles and 900 MHz cryoplatform. The solicitation sought these upgrades to maintain high quality research capabilities at NIDDK....
This purchase order award from the Department of Health and Human Services' National Institutes of Health to Bruker Biospin Corp. is for $209,888.76 to provide annual maintenance services for various Bruker NMR spectrometers and a CryoPlatform system located at the NIH campus in Bethesda, Maryland. The period of performance is from September 11, 2018 through September 16, 2019. The solicitation sought quotes for preventative maintenance from the original equipment manufacturer to support...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, awarded a firm-fixed-price purchase order to Bruker Biospin Corp, a subsidiary of Bruker Corporation, to acquire a service contract for a CryoPlatform system. The $216,845.10 contract will be performed in Billerica, Massachusetts and has an ultimate completion date of September 27, 2023. The contract was awarded on September 28, 2022, and did not utilize any set-aside designations. The original...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), awarded a $63,066 firm-fixed-price purchase order to Bruker Nano, Inc. (doing business as Bruker Nano Surfaces Division) for a preventive maintenance agreement on a JPK NanoWizard atomic force microscope system. This specialized instrument is used by NIDDK's intramural research program to conduct mechanical characterization and cell-cell adhesion measurements in...
This federal contract award, valued at $222,075.00, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Bruker Biospin Corp, a subsidiary of Bruker Corporation. The contract is for a CRYOPLATFORM with annual maintenance services. The original solicitation was a pre-solicitation non-competitive notice, indicating Bruker Biospin Corp was the sole source for the required services. The contract does not have a set-aside designation....
The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $587,061 firm fixed price purchase order to Bruker Biospin Corp. to acquire an Avance Neo 700 MHz NMR console compatible with an existing 700 MHz spectrometer located at NIH's campus in Bethesda, Maryland. The solicitation sought quotes for the NMR equipment upgrade by September 5, 2023, with delivery and installation within six to nine months of award. Evaluation factors included...
The U.S. Department of Health and Human Services, National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $2,855,935.00 firm-fixed-price contract to Bruker Biospin Corp, a for-profit manufacturer, to provide five Avance Neo consoles for Bruker NMR spectrometers, a Q-band pulse 300 W amplifier for a Q-band pulsed EPR spectrometer, and two cryoplatforms for Bruker NMR spectrometers. This award supports upgrading the NMR and EPR...
The National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency, awarded a $185,250 firm fixed-price purchase order to Bruker Biospin Corp, a for-profit manufacturer, for the delivery of a nuclear magnetic resonance (NMR) spectrometer. This award is not associated with any set-aside program. Bruker Biospin Corp is a subsidiary of the larger Bruker Corporation, which provides a wide range of analytical and detection equipment and services to various U.S. government...